Prazosin for PTSD Nightmares: What the Evidence Shows

Prazosin is a blood pressure medicine. Its only FDA-approved use is treating hypertension, so prescribing it for PTSD nightmares is off-label. The evidence is genuinely mixed: smaller trials found it reduced trauma nightmares, but the largest trial, in 304 veterans, found no difference from placebo.

Guidelines reflect that uncertainty. The American Academy of Sleep Medicine (AASM) says prazosin "may be used" for PTSD-associated nightmares and reserves its only "recommended" rating for imagery rehearsal therapy, a talk-based treatment. The 2023 VA/DoD PTSD guideline gives prazosin a weak recommendation for nightmares. In practice, that makes prazosin a reasonable thing to try with a prescriber who monitors your blood pressure, not a sure bet.

Prazosin at a glance

Off-label means this use is not on the FDA-approved label, so you and your prescriber are weighing published studies and guidelines instead of an approved indication.

Why a blood pressure drug for nightmares?

Prazosin blocks alpha-1 adrenergic receptors, which reduces adrenaline-related (sympathetic) signaling from the brain. Researchers tested it in PTSD because several brain processes implicated in PTSD, including some sleep and nightmare phenomena, are regulated by these receptors. The clinical trials described below are the real test of that theory, and they point in different directions.

It helps to be clear about what prazosin is not. It does not knock you out the way a hypnotic does, and it is not a treatment for PTSD as a whole. The 2023 VA/DoD guideline suggests against prazosin for treating PTSD overall, while separately suggesting it for nightmares associated with PTSD. If your main problems are daytime intrusive memories, avoidance or hypervigilance, trauma-focused therapy is the core treatment; our guide to CPT, prolonged exposure and EMDR compares those options.

What the trials found

The earlier positive trials

Several randomized trials in veterans and service members reported that prazosin reduced trauma nightmares. One of the most cited is a 2013 trial in the American Journal of Psychiatry: 67 active-duty soldiers who had returned from Iraq and Afghanistan were randomly assigned to prazosin or placebo for 15 weeks. Prazosin improved trauma nightmares, sleep quality, global functioning and overall PTSD scores, was well tolerated, and blood pressure changes did not differ between the groups.

The large VA trial that found no benefit

In 2018 the New England Journal of Medicine published a much larger VA trial. It enrolled 304 veterans with chronic PTSD and frequent nightmares at 13 VA medical centers and followed them for 26 weeks. At 10 weeks, prazosin was no better than placebo for distressing dreams, sleep quality or overall clinical change, and there were still no significant differences at 26 weeks. The authors concluded that in this group, prazosin did not alleviate distressing dreams or improve sleep quality.

Two safety findings from that trial are worth knowing. Supine systolic blood pressure fell more on prazosin, with a mean difference of 6.7 mm Hg at 10 weeks. New or worsening suicidal ideation was reported in 8% of participants on prazosin and 15% on placebo, so the trial did not suggest prazosin raised that risk.

Making sense of the conflict

Neither trial explains the gap on its own. The populations differed, with active-duty soldiers returned from Iraq and Afghanistan in one and veterans with chronic PTSD in the other, and the 2018 trial enrolled more than four times as many participants. Whether prazosin works better for some groups than others is not established. What the evidence supports is a modest, uncertain chance of benefit that has to be weighed against side effects for each person.

What guidelines say now

The AASM published its position paper on nightmare disorder in adults in 2018, after reviewing studies published between March 2009 and August 2017. It rated imagery rehearsal therapy as the one treatment "recommended" for both PTSD-associated nightmares and nightmare disorder. Prazosin moved to "may be used," and the task force said it agreed unanimously to downgrade prazosin because of the contradictory VA trial. The same paper lists clonazepam and venlafaxine as not recommended for nightmare disorder.

The VA/DoD guideline, version 4.0 from 2023, reaches a slightly different balance. It suggests prazosin for nightmares associated with PTSD (a weak recommendation) and finds insufficient evidence to recommend for or against imagery rehearsal therapy, exposure, relaxation and rescripting therapy, imagery rescripting and reprocessing therapy, or the NightWare device.

The honest summary is that two respected bodies read the same thin evidence differently. Neither says prazosin is ineffective for everyone, and neither calls it a first-line certainty.

Side effects and safety

Because prazosin lowers blood pressure, its most important risk is fainting. The label warns that, as with all alpha-blockers, it can cause syncope with sudden loss of consciousness, usually within 30 to 90 minutes of the first dose. Syncope occurred in about 1% of patients given a first dose of 2 mg or more, and the label says the risk can be minimized with a low starting dose and slow increases. Your prescriber sets the dose and the pace; never adjust it on your own.

In the hypertension trials behind the label, the most frequent reactions were dizziness (10.3%), headache (7.8%), drowsiness (7.6%), lack of energy (6.9%), weakness (6.5%), palpitations (5.3%) and nausea (4.9%). The label notes that these often faded with continued treatment.

• The label advises avoiding driving or hazardous tasks for the first 24 hours after the first dose or a dose increase.
• Dizziness or fainting is more likely when getting up quickly, after alcohol, during exercise, in hot weather or after standing a long time; the label advises rising slowly.
• Adding a diuretic or another blood pressure drug has an additive effect, and low blood pressure can develop with beta-blockers such as propranolol. This matters if you also take propranolol for anxiety; see our article on propranolol for performance anxiety.
• Tell your eye surgeon before cataract surgery: a complication called intraoperative floppy iris syndrome has been seen in people taking alpha-1 blockers.

The label links dizziness and fainting to rising from lying or sitting, so nighttime trips to the bathroom deserve a plan. Sitting on the edge of the bed for a moment before standing is a simple habit your prescriber may suggest.

Imagery rehearsal therapy and other non-drug options

Imagery rehearsal therapy (IRT) works on the nightmare itself. You choose a recurring nightmare, rewrite its content into a new set of images, and rehearse the rewritten version while awake for 10 to 20 minutes a day. It is the only nightmare treatment the AASM rates as recommended. It takes daily practice, and the VA/DoD guideline considers the evidence insufficient to recommend for or against it, so it is not guaranteed either.

The AASM also lists cognitive behavioral therapy, CBT for insomnia and EMDR among treatments that may be used for PTSD-associated nightmares. Nightmares often sit alongside broader insomnia; our comparison of insomnia treatment options covers CBT-I in detail, and the drlewis.com article on why sleep matters in trauma recovery explains the connection.

Many people combine approaches: trauma-focused therapy for PTSD as a whole, IRT or CBT-I for sleep, and a medication trial if nightmares remain severe. Combining is a decision to make with your clinicians, not a fixed sequence.

What a prazosin trial usually looks like

A medication trial for nightmares is a structured experiment, not an open-ended prescription. The details vary by prescriber, but the outline below follows how the research trials were run and what the label asks for.

1. Baseline. Your prescriber reviews your blood pressure, other medicines, alcohol use and any history of fainting, and asks how often nightmares occur and how distressing they are.
2. A low start. The label describes starting low and increasing slowly to limit first-dose fainting. Your prescriber gives the exact timing and dose, and because fainting usually occurs within 30 to 90 minutes of the first dose, it helps to know in advance where you will be during that window.
3. Gradual increases. In the trials, doses were raised step by step over five to six weeks, guided by nightmare response and side effects.
4. Monitoring. Blood pressure, dizziness and daytime energy are checked along with nightmare frequency and sleep quality.
5. A decision point. If nightmares have not meaningfully improved after an adequate trial, the PACT results are a reasonable argument for stopping and trying something else rather than pushing the dose indefinitely. How to stop is your prescriber's call.

Nightmares and insomnia overlap but are not the same problem. Some people stop having nightmares and still lie awake for hours, often because the bedroom has become linked with fear. If that describes you, a treatment aimed at insomnia itself may matter as much as anything aimed at dreams, and a sleep evaluation may be worth discussing; our article on sleep studies versus insomnia treatment explains when testing helps.

Is a prazosin trial reasonable for you?

If another sleep medicine is also being considered, our guide to sleep medications compared explains how hypnotics, orexin blockers and sedating antidepressants differ from prazosin, and hydroxyzine vs benzodiazepines covers anxiety medicines sometimes used at night. The AASM does not recommend clonazepam for nightmare disorder.

Questions to ask your prescriber

1. Given the mixed trial results, what benefit would make this worth continuing, and by when will we judge it?
2. How will my blood pressure be checked, at home and at visits?
3. How does prazosin interact with my other medicines, including anything for blood pressure, prostate symptoms or erectile dysfunction?
4. What should I do if I feel faint or fall?
5. Can I combine this with imagery rehearsal therapy or trauma-focused therapy?
6. If it does not help, what is the plan for stopping it and what comes next?

Bring a simple log to follow-up visits: nightmares per week, how distressing they were, hours slept, and any dizziness. The trials measured nightmare frequency and distress and sleep quality, so tracking the same things gives your prescriber something concrete to judge. Our overview of what to expect from medication management describes how follow-up visits usually work.

How Dr. Lewis's practice approaches trauma-related sleep problems

The practice offers psychiatric evaluation and medication management alongside psychotherapy, including CBT and DBT, so medication decisions and therapy can be planned by one team. Psychiatrists, psychiatric nurse practitioners and psychotherapists work together there. You can read how the practice describes the role of medication in PTSD treatment, or start with the Patient Interest Form. For more comparisons like this one, see the Choosing Psychiatric Care guide.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

Frequently asked questions

How long does prazosin take to work for nightmares?

In the main trials the dose was raised gradually over five to six weeks before outcomes were judged, so a fair trial is measured in weeks, not nights. Your prescriber decides the pace and when to reassess.

Can I drink alcohol while taking prazosin?

The prazosin label says dizziness, lightheadedness and fainting may also occur if you drink alcohol, and advises being careful about how much you drink. Ask your prescriber what is safe for you.

Does prazosin help nightmares that are not from PTSD?

The AASM position paper lists prazosin among treatments that may be used for nightmare disorder as well as PTSD-associated nightmares, and recommends imagery rehearsal therapy for both. The evidence base is mostly from PTSD studies.

Will prazosin make me sleepy during the day?

Drowsiness and lack of energy were among the more frequent side effects in the label's trials, though they often faded with continued use. Prazosin is not a hypnotic, so tell your prescriber if daytime tiredness persists.

Is prazosin a controlled substance or habit-forming?

No. Prazosin is a prescription blood pressure medicine, not a controlled sedative. Any decision to stop it should still be planned with your prescriber, especially if you take other blood pressure medicines.

What if prazosin does not help?

Given the mixed evidence, that is a real possibility. Options include imagery rehearsal therapy, trauma-focused psychotherapy, CBT for insomnia, and other medicines your prescriber may consider. See our insomnia treatment comparison.

Sources

1. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. New England Journal of Medicine (Raskind et al.), 2018. pubmed.ncbi.nlm.nih.gov
2. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry (Raskind et al.), 2013. pubmed.ncbi.nlm.nih.gov
3. Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper. Journal of Clinical Sleep Medicine (Morgenthaler et al.), 2018. pmc.ncbi.nlm.nih.gov
4. VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder: Quick Reference Guide (Version 4.0). U.S. Department of Veterans Affairs and Department of Defense, 2023. healthquality.va.gov
5. Prazosin hydrochloride capsules prescribing information. DailyMed / U.S. FDA label, 2023. dailymed.nlm.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.